Supreme Court Won't Hear Howmedica Polymer IP Appeal

Law360, New York (May 16, 2011, 9:01 PM EDT) -- The U.S. Supreme Court declined Monday to hear Howmedica Osteonics Corp.'s challenge to a decision that three Howmedica patents were invalid, nixing the company's bid to prevent the Federal Circuit from treating patent indefiniteness as a question of pure law.

The high court denied Howmedica's March 14 petition for writ of certiorari, in which the Stryker Corp. unit sought clarification on whether patent invalidity for indefiniteness should be analyzed as a pure question of law, as the Federal Circuit asserts, or as a question of fact...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.